We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.25T
AUM Growth
-$1.02T
Cap. Flow
-$1.16T
Cap. Flow %
-93.16%
Top 10 Hldgs %
19.22%
Holding
8,154
New
333
Increased
458
Reduced
6,748
Closed
331

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.9B
2
AAPL icon
Apple
AAPL
+$38.9B
3
AMZN icon
Amazon
AMZN
+$26B
4
NVDA icon
NVIDIA
NVDA
+$23.3B
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17B

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 10.81%
3 Healthcare 9.76%
4 Consumer Discretionary 9.08%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLGO
2726
Pelagos Insurance Capital
PLGO
$2.18B
$19.4M ﹤0.01%
997,218
+621,892
+166% +$9.16M
TBBK icon
2727
The Bancorp
TBBK
$2.99B
$19.4M ﹤0.01%
580,360
-507,354
-47% -$20.2M
IPGP icon
2728
IPG Photonics
IPGP
$3.89B
$19.4M ﹤0.01%
214,069
-384,957
-64% -$36.2M
VSTO
2729
DELISTED
Vista Outdoor Inc.
VSTO
$19.4M ﹤0.01%
592,009
-652,701
-52% -$19.8M
AVLV icon
2730
Avantis US Large Cap Value ETF
AVLV
$18.1B
$19.4M ﹤0.01%
301,896
+152,440
+102% +$9.14M
PFFV icon
2731
Global X Variable Rate Preferred ETF
PFFV
$304M
$19.4M ﹤0.01%
817,236
-236,408
-22% -$5.58M
NDMO icon
2732
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$600M
$19.3M ﹤0.01%
1,776,488
-1,663,128
-48% -$17.6M
LMND icon
2733
Lemonade
LMND
$4.03B
$19.3M ﹤0.01%
1,178,491
+51,219
+5% +$861K
ATS icon
2734
ATS Corp
ATS
$2.71B
$19.3M ﹤0.01%
573,413
-336,155
-37% -$13.3M
HAYN
2735
DELISTED
Haynes International, Inc.
HAYN
$19.3M ﹤0.01%
321,507
+9,419
+3% +$543K
EVH icon
2736
Evolent Health
EVH
$346M
$19.3M ﹤0.01%
588,600
-568,270
-49% -$18.1M
BASE
2737
DELISTED
Couchbase
BASE
$19.3M ﹤0.01%
732,555
-1,296,589
-64% -$33.7M
RNG icon
2738
RingCentral
RNG
$5.16B
$19.2M ﹤0.01%
553,945
-1,572,943
-74% -$52.9M
RIV
2739
RiverNorth Opportunities Fund
RIV
$317M
$19.2M ﹤0.01%
1,596,001
-1,438,539
-47% -$16.7M
INBX
2740
DELISTED
Inhibrx, Inc. Common Stock
INBX
$19.2M ﹤0.01%
549,469
-44,369
-7% -$1.62M
ONC
2741
BeOne Medicines Ltd
ONC
$34B
$19.2M ﹤0.01%
122,778
-199,290
-62% -$32.1M
FMS icon
2742
Fresenius Medical Care
FMS
$12.8B
$19.2M ﹤0.01%
995,706
-907,292
-48% -$18M
LEGN icon
2743
Legend Biotech
LEGN
$3.69B
$19.2M ﹤0.01%
342,033
-1,438,941
-81% -$86.8M
ASPN icon
2744
Aspen Aerogels
ASPN
$415M
$19.2M ﹤0.01%
1,089,803
-240,603
-18% -$3.55M
USTB icon
2745
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.33B
$19.2M ﹤0.01%
384,331
-301,623
-44% -$15M
KROS icon
2746
Keros Therapeutics
KROS
$198M
$19.1M ﹤0.01%
289,157
-1,561,619
-84% -$92.6M
AMK
2747
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$19.1M ﹤0.01%
539,965
+177,211
+49% +$5.79M
NX icon
2748
Quanex
NX
$959M
$19.1M ﹤0.01%
497,221
-597,609
-55% -$19.9M
BUG icon
2749
Global X Cybersecurity ETF
BUG
$1.45B
$19.1M ﹤0.01%
640,860
-364,812
-36% -$10.9M
LZB icon
2750
La-Z-Boy
LZB
$1.66B
$19.1M ﹤0.01%
506,462
-596,652
-54% -$21.8M

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
  • Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.